Figure 1From: Comparison of bioavailability between the most available generic tablet formulation containing artemether and lumefantrine on the Tanzanian market and the innovator’s productMean plasma concentration-time profiles of lumefantrine in 18 health volunteers after oral administration of either a 20/120 mg Coartem® or Artefan® (generic) tablet formulation. Error- Bars represent mean ± standard error.Back to article page